XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash Flow From Operating Activities:      
Net income $ 5,251 $ 475,317 $ 6,445
Adjustments to reconcile net income to net cash used in operating activities:      
Loss (gain) on sale, remeasurement or write down of assets 1,923 (87,132) (24,647)
(Gain) loss on foreign currency transactions (993) (20,067) 6,175
Loss on early debt extinguishment 1,710 2,805 1,451
Depreciation and amortization 14,571 13,111 15,029
Provision (recovery) for doubtful accounts 1,593 (3,284) (1,326)
Equity in income from unconsolidated joint ventures (3,242) (469,268) (14,634)
Distribution of income from unconsolidated joint ventures 0 5,200 3,157
Changes in assets and liabilities, net of acquisitions and dispositions:      
Other assets (10,273) 7,782 (14,205)
Related party receivables (11,081) (7,585) 18,246
Accrued interest payable (1,719) (1,318) (4,650)
Accounts payable and other liabilities (28,794) 39,053 (2,564)
Net cash used in operating activities (31,054) (45,386) (11,523)
Cash Flow From Investing Activities:      
Collection of notes receivable 1,967 3,027 18,171
Originations and advances on notes receivable (6,500) (2,305) (4,968)
Purchase of short-term investments (91,007) (277,641) (16,000)
Redemption of short-terms investments 120,346 175,250 0
Development and renovation of real estate (18,462) (18,686) (8,070)
Deferred leasing costs (1,128) (1,163) (877)
Proceeds from sale of assets 188 44,591 105,547
Contribution to unconsolidated joint venture 0 0 (411)
Distributions from unconsolidated joint ventures 21,409 384,284 7,430
Net cash provided by investing activities 26,813 307,357 100,822
Cash Flow From Financing Activities:      
Proceeds from mortgages and other notes payable 0 0 20,015
Payments on mortgages, other notes and bonds payable (137,657) (111,022) (118,900)
Repurchase of treasury shares by IOR (908) 0 0
Debt extinguishment costs (435) (1,355) (4,086)
Deferred financing costs (20) 0 (614)
Net cash used in financing activities (139,020) (112,377) (103,585)
Net (decrease) increase in cash and cash equivalents (143,261) 149,594 (14,286)
Cash and cash equivalents, beginning of year 222,328 72,734 87,020
Cash and cash equivalents, end of year $ 79,067 $ 222,328 $ 72,734